The company reported sales of RON77.2 million and profit of RON17.3 million in January-September 2012.
Exports account for 3.5% of Biofarm’s total turnover. The company exports medicines to the Republic of Moldova, Russia, Ukraine, Azerbaijan, Belarus, Georgia, Serbia, Kazakhstan and Hungary, and soon to the Czech Republic and Slovakia.
The shareholding structure of Biofarm changed two weeks ago, after regional investment fund SIF Oltenia (SIF5.RO) sold its entire stake in Biofarm (315 million shares) to SIF Muntenia (SIF4.RO) (indirectly owned by SIF Crisana-Banat) for RON96.075 million. SIF Moldova (SIF2.RO) controls 13.3% in Biofarm.
Biofarm closed down 0.8% Monday, at RON0.2862 a share. Considering this price, the company has a market capitalization of RON313.3 million.
The company employs over 350 people. (EUR1=RON4.4531)